Hims Hers Health Inc (HIMS) — Technical state
As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 36 out of 100 (momentum 26 · quality 32 · valuation 22), as of 2026-11-11.
- Signal: Mixed moving-average stack — Trades -31.9% vs the 50-day and -28.7% vs the 200-day average, 55.2% below the 52-week high and +39.2% off the 52-week low; a golden cross printed 73 sessions ago. Computed from daily closes. (as of 2026-11-10)
- Trend: Hims Hers Health Inc trades 31.9% below its 50-day and 28.7% below its 200-day moving average. (as of 2026-11-10)
Hims & Hers Health runs a direct-to-consumer platform that links patients online with licensed clinicians for prescription and over-the-counter care. It sells personalised treatments and products across skincare, hair care, sexual health, weight loss, hormone health and mental health, alongside lab testing that checks a range of body markers.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the HIMS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades -31.9% vs the 50-day and -28.7% vs the 200-day average, 55.2% below the 52-week high and +39.2% off the 52-week low; a golden cross printed 73 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day-29.2%
- vs 50-day-31.9%
- vs 200-day-28.7%
- 52-week band55.2% off the high · +39.2% off the low
- Streak2 consecutive down sessions
- CrossoverGolden cross 73 sessions ago
- 50-day crossprice crossed down through the 50-day 7 sessions ago
- Stochastic%K 6.2 · %D 20.7 · bear cross
Continue: the HIMS chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-10
Quick answers
What is the current Closelooknet signal on HIMS?
Mixed moving-average stack — Trades -31.9% vs the 50-day and -28.7% vs the 200-day average, 55.2% below the 52-week high and +39.2% off the 52-week low; a golden cross printed 73 sessions ago. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is HIMS above its 50-day and 200-day moving averages?
As of 2026-11-10, Hims Hers Health Inc trades -31.9% below its 50-day and -28.7% below its 200-day average, with the 20-day -29.2% away.
How far is HIMS from its 52-week high?
55.2% below the 52-week high and 39.2% above the 52-week low, as of 2026-11-10.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- IRWD Ironwood Pharmaceuticals Incindustry
- LNTH Lantheus Holdings Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- GALDY GALDERMA GROUP AGindustry
- ALM.MC Almirall S.A.industry
- XERS Xeris Pharmaceuticals Incindustry
- HLUN-B.CO H Lundbeck A/Sindustry
- ETON Eton Pharmaceuticals Incindustry
- PCRX Pacira BioSciences, Inc.industry
- VTRS Viatris Incindustry
- ELAN Elanco Animal Healthindustry
- NBIX Neurocrine Biosciences Incindustry
- AMPH Amphastar Pindustry
- GUD.TO Knight Therapeutics Inc.industry
- PRGO Perrigo Company PLCindustry
- VETO.PA Vetoquinolindustry
- HCM HUTCHMED DRCindustry
- UTHR United Therapeutics Corporationindustry
- DHT-UN.TO DRI Healthcare Trustindustry